Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, July 11, 2023 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture philanthropy organization catalyzing innovation and removing barriers to accelerate new therapies for FSHD,...
-
VANCOUVER, British Columbia, April 18, 2023 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture-philanthropic organization catalyzing the pace of innovation to accelerate a cure for FSHD, announced today an...
-
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- In a release issued today by SOLVE FSHD under the same headline, please note that the embedded link for Vita Therapeutics in paragraph...
-
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture-philanthropic organization catalyzing the pace of innovation to accelerate a cure for facioscapulohumeral...
-
VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture-philanthropy organization catalyzing the pace of innovation to accelerate a cure for FSHD, announced today an...
-
VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- In an announcement issued earlier today under the same headline by SOLVE FSHD, please be advised that in the second paragraph,...
-
VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- SOLVE FSHD, the venture-philanthropy organization founded by entrepreneur Chip Wilson, announces its financial support to the FSHD Canada...
-
VANCOUVER, Columbia Británica, May 11, 2022 (GLOBE NEWSWIRE) -- Posteriormente al aclamado reciente lanzamiento de SOLVE FSHD, la organización se complace en anunciar formalmente...
-
캐나다 브리티시컬럼비아주 밴쿠버, May 12, 2022 (GLOBE NEWSWIRE) -- 최근 출범해 주목을 받은 SOLVE FSHD는 Dr. Eva Chin을 이사로 선임한다고 공식 발표했다. SOLVE FSHD 창립자인 Chip Wilson은 자신이 32살에 진단받은 희귀병 안면견갑상완 근디스트로피 치료제를 개발하기 위해 사비 1억 달러를...
-
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Nach der kürzlich erfolgten, viel beachteten Gründung von SOLVE FSHD freut sich die Organisation, die Ernennung von Dr. Eva Chin zur...